GGrantIndex
← Leaderboards

Christopher Davies

Virginia Commonwealth University

$9,982,016
Attributed
$11,375,709
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,375,709 · 8

By mechanism

R01$8,186,435 · 2
U01$2,090,540 · 1
P20$562,733 · 3
R21$411,125 · 1
S10$124,876 · 1

Top collaborators

Most similar at Virginia Commonwealth University

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsInfectionStructureMolecularMutationNeisseria GonorrhoeaePeptidoglycanCephalosporinsAntimicrobialResistanceAntibioticsOrganismAntibiotic ResistanceVariantGonorrheaCefiximeCeftriaxoneMutantX-Ray CrystallographyPeptidesPeptidyltransferaseComplexAcylationMonobactams

Grant awards (31)

Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2$696,185
R01 · FY2025 · AI · contact PI
PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease$669,937
U01 · FY2025 · AI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2$696,246
R01 · FY2024 · AI · contact PI
PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease$674,594
U01 · FY2024 · AI
PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease$746,009
U01 · FY2023 · AI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2$697,600
R01 · FY2023 · AI · contact PI
Molecular mechanism of cephalosporin resistance of N. gonorrhoeae conferred by mutated PBP2$728,298
R01 · FY2022 · AI · contact PI
Molecular targets in peptidoglycan synthesis$500,940
R01 · FY2019 · GM · contact PI
Molecular targets in peptidoglycan synthesis$431,711
R01 · FY2018 · GM · contact PI
Supplement to Molecular Targets in Peptidoglycan Synthesis$56,100
R01 · FY2018 · GM · contact PI
Molecular targets in peptidoglycan synthesis$431,711
R01 · FY2017 · GM · contact PI
Molecular targets in peptidoglycan synthesis$468,164
R01 · FY2016 · GM · contact PI
Molecular Targets in Peptidoglycan Synthesis$335,984
R01 · FY2015 · GM · contact PI
Targeting P. aeruginosa penicillin-binding proteins for drug discovery$186,875
R21 · FY2015 · AI · contact PI
Molecular Targets in Peptidoglycan Synthesis$335,984
R01 · FY2014 · GM · contact PI
Targeting P. aeruginosa penicillin-binding proteins for drug discovery$224,250
R21 · FY2014 · AI · contact PI
Molecular Targets in Peptidoglycan Synthesis$324,225
R01 · FY2013 · GM · contact PI
Molecular Targets in Peptidoglycan Synthesis$347,859
R01 · FY2012 · GM · contact PI
Crystallization robotics to support X-ray crystallography at MUSC$124,876
S10 · FY2011 · RR · contact PI
Molecular Targets in Peptidoglycan Synthesis$289,080
R01 · FY2010 · GM · contact PI
SC COBRE: PROTEIN SCIENCE CORE$129,115
P20 · FY2010 · RR · contact PI
Molecular Targets in Peptidoglycan Synthesis$292,000
R01 · FY2009 · GM · contact PI
SC COBRE: PROTEIN SCIENCE CORE$218,998
P20 · FY2009 · RR · contact PI
Molecular Targets in Peptidoglycan Synthesis$177,917
R01 · FY2009 · GM · contact PI
Molecular Targets in Peptidoglycan Synthesis$292,184
R01 · FY2008 · GM · contact PI
SC COBRE: PROTEIN SCIENCE CORE$214,620
P20 · FY2008 · RR · contact PI
Molecular Targets in Peptidoglycan Synthesis$303,500
R01 · FY2007 · GM · contact PI
Molecular Targets in Peptidoglycan Synthesis$187,122
R01 · FY2006 · GM · contact PI
Molecular Targets in Peptidoglycan Synthesis$191,625
R01 · FY2005 · GM
Molecular Targets in Peptidoglycan Synthesis$191,625
R01 · FY2004 · GM
Molecular Targets in Peptidoglycan Synthesis$210,375
R01 · FY2003 · GM